Maes M, Galecki P, Chang YS, Berk M
Scott Butsch, who is director of obesity medicine at the Cleveland Clinic in Ohio, who was not involved in the research
weighted hazard ratio 1.02, 0.85 to 1.23) (table 3)
During rest, when tissue restoration takes place naturally, this peptide can operate effectively
On that basis, tesamorelin has the higher-tier and more recent human data multiple randomized, placebo-controlled Phase 3 trials while sermorelins human record is older and narrower
That's the point at which regulators assess whether the product should have market authorisation based on the evidence package submitted